Viewing nowCombinationTelmisartan and Amlodipine Dual Tablets 40/5 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
LightPharmTech Co., Ltd.

MFDS item code 201903310 · Approved 2019.05.22 · Insurance code 690301050
Treatment of essential hypertension not controlled by monotherapy
This medication can be used in patients with essential hypertension whose blood pressure is not sufficiently controlled with either amlodipine or telmisartan monotherapy. It effectively lowers blood pressure and helps improve hypertension.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this drug; however, direct switching to this drug may be considered if blood pressure is not controlled with the individual components, as follows. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. For patients taking telmisartan and amlodipine concomitantly, switching to this drug (a combination product containing the same amounts of each active ingredient) may be considered for convenience (limited to this drug 40/5 milligrams). ○ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution in Administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
○ Children: Safety and efficacy have not been established in pediatric patients 18 years of age or younger; therefore, administration of this drug is not recommended.
This medication must not be taken during pregnancy, especially in the second and third trimesters, as it may pose serious risks to the fetus. It should not be used in patients with a known allergy to the active ingredients or similar components, women who are pregnant or may become pregnant, nursing mothers, patients with severe liver or heart problems, and those with certain kidney diseases. Patients with impaired liver function, gastrointestinal disorders, renal vascular issues, severe heart failure, and the elderly should exercise special caution when using this medication. Common side effects may include dizziness, edema, and hypotension, while serious side effects such as fainting and cardiac issues have been reported rarely. This medication should not be used during pregnancy; if pregnancy is confirmed, it should be discontinued immediately and replaced with other safe treatment alternatives. As this drug lowers blood pressure, patients who are hypotensive or dehydrated should consult healthcare professionals before taking it, and regular monitoring of blood pressure and kidney function is necessary during use. Additionally, this medication can interact with other drugs, so patients should inform their healthcare providers of any other medications they are taking. Caution is advised when driving or operating machinery, as dizziness or drowsiness may occur. In case of overdose, severe hypotension or cardiac issues may occur, and immediate medical attention should be sought. This medication is not recommended for children, and it should be stored out of reach of children and protected from moisture.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in an opaque container. It is important to maintain a room temperature between 1 to 30 degrees Celsius when storing the medication, to preserve its efficacy and safety over time.
Biconvex oval bicolor tablet in white and light gray
30 tablets/box [(10 tablets/PTP X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
LightPharmTech Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.